We are Sorry, This Page doesn't Exist
Thermo Fisher seeks to buy pharma services company PPD for $15 billion: report
Thermo Fisher Scientific Inc. is approaching a deal to buy pharmaceutical-testing company PPD Inc. for more than $15 billion, the Wall Street Journal reported W.....»»
Vincera Pharma announces formation of Scientific Advisory Board
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
aTyr Pharma appoints Judith Varner as scientific advisor
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AIkido Pharma appoints Dr. Scott Tagawa, M.D. to Scientific Advisory Board
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AIkido Pharma appoints Neil Bander to its Scientific Advisory Board
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Key Words: Trump again touts unproven drug to treat coronavirus: ‘What do you have to lose?’
President Donald Trump on Sunday again strongly backed hydroxychloroquine to treat patients with COVID-19, despite scant scientific evidence that it’s an effective treatment......»»
Boston Scientific sees Q1 revenue flat to up slightly as coronavirus delays elective procedures
Boston Scientific Corp. said Thursday it expects first-quarter revenue growth to be flat to up slightly versus the year-earlier pe.....»»
aTyr Pharma appoints Arthur Mercurio as scientific advisor
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Top Takeaways from AP"s report on Italy"s "Pain League"
An Associated Press investigation finds that managers with Purdue Pharma's international arm — Mundipharma — have been caught up in a sprawling corruption case in Italy alleging they paid a prominent pain doctor to help push opioids......»»
FSD Pharma Names 3 To Scientific Advisory Board
FSD Pharma Inc (OTC: FSDDF), a company engaged in development of medical cannabis and research on cannabinoid-based treatments, announced the addition Monday of three major cannabis researchers to its scientific advisory board. read more.....»»
Kala Pharmaceuticals (KALA) Reports Q1 Loss, Tops Revenue Estimates
Kala Pharma (KALA) delivered earnings and revenue surprises of 17.28% and 43.78%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Want the latest.....»»
Modi government completes four years in office: A look at who said what
Amit Shah says that the agenda in 2019 Lok Sabha elections would be 'BJP's corruption Hatao versus Opposition's Modi Hatao'.....»»
Give life sciences space and watch it boom
With tech startups and the world’s best scientific and medical-research universities, New York City has long been at the crossroads of technology, science and medicine. Workers in pharma,... To view the full story, click the title link......»»
Boston Scientific, Edwards Lifesciences May Tempt J&J
Either device maker could be a rewarding acquisition for the old-line pharma and consumer-product company.....»»
Boston Scientific (BSX) Q4 Earnings and Revenues Beat Estimates
Boston Scientific (BSX) delivered earnings and revenue surprises of 5.41% and 0.11%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock? Want the latest recommendations from .....»»
Scientific Games (SGMS) Q4 Earnings and Revenues Beat Estimates
Scientific Games (SGMS) delivered earnings and revenue surprises of 130.00% and 1.30%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock? Want the l.....»»
"Ozempic face" could create a huge market for fillers. One newly-public company wants to cash in.
Flemming Ornskov, the CEO of Galderma, said that the Ozempic face phenomenon could be a boost for its fillers business. E+/Getty ImagesSwiss pharma giant Galderma sees opportunity in the "Ozempic face" phenomenon.Its C.....»»
Royal Caribbean Cruises Through Q1 As Demand And Pricing Remains High
Royal Caribbean saw Q1 passenger ticket revenue reach $2.54 billion, a 34% year-over-year increase versus Q1 2023. read more.....»»
Cannabis Saga In The Empire State: Corruption Or Ineptitude? Private Equity Tramples Social Equity, Report Reveals
NY's public-private fund for social equity retailers is under scrutiny after a report uncovers a "lopsided deal" for a private equity firm. read more.....»»
Boston Scientific Q1 Earnings and Revenues Top Estimates
Boston Scientific (NYSE: BSX) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings.....»»